2020
Search results
Jul 5, 2024 · Jennifer Doudna (born February 19, 1964, Washington, D.C.) is an American biochemist best known for her discovery, with French microbiologist Emmanuelle Charpentier, of a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9.
- Kara Rogers
Jun 26, 2024 · Emmanuelle Charpentier and Jennifer Doudna. developers of the Crispr-Cas9 “genetic scissors” technique, won the Nobel chemistry prize in 2020. Last year, a gene editing therapy to target the...
Jun 26, 2024 · Jennifer Doudna won a Nobel Prize for developing a powerful gene-editing technology. What comes next for CRISPR?
Jun 29, 2024 · Jennifer A. Doudna is the founder of Caribou Biosciences, Inc. (founded in 2011), Editas Medicine, Inc. (founded in 2013), Intellia Therapeutics, Inc. (founded in 2014), and the Innovative Genomics Institute (founded in 2014). She is also the founder of Mammoth Biosciences, Inc., Scribe Therapeutics, Inc...
Jul 2, 2024 · The book follows Jennifer Doudna's life story from her early years in Hawaii, through her academic career, to her ground-breaking work creating CRISPR-Cas9, a tool that enables scientists to precisely alter genes.
Jun 21, 2024 · If it’s to reach its full potential, scientists must develop new delivery methods, said CRISPR pioneer Dr. Jennifer Doudna during an NIH Director’s Lecture in Masur Auditorium.
Jul 2, 2024 · Jennifer A. Doudna is the Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences; Professor of Molecular and Cell Biology; and Professor of Chemistry at the University of California, Berkeley. She is also an Investigator of the Howard Hughes Medical Institute.
